Fidelity International’s Cogent Biosciences COGT Stock Holding History

Fidelity International’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-169,931	Closed	-$313K	–	939
2020 Q2	$313K	Sell	169,931 -25,925	-13%	-$48.1K	﹤0.01%	647
2020 Q1	$324K	Hold	195,856	–	–	﹤0.01%	638
2019 Q4	$564K	Hold	195,856	–	–	﹤0.01%	669
2019 Q3	$1.13M	Hold	195,856	–	–	﹤0.01%	621
2019 Q2	$2.05M	Hold	195,856	–	–	﹤0.01%	605
2019 Q1	$3.44M	Hold	195,856	–	–	0.01%	540
2018 Q4	$3.45M	Sell	195,856 -79,646	-29%	-$2.36M	0.01%	545
2018 Q3	$11.3M	Sell	275,502 -9,067	-3%	-$511K	0.02%	472
2018 Q2	$16.3M	Hold	284,569	–	–	0.02%	423
2018 Q1	$13.7M	Buy	+284,569	New	+$12.6M	0.04%	319

Other funds holding COGT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Fidelity International's COGT Position: Q3 2020 in Review

Fidelity International sold out of Cogent Biosciences (COGT) in Q3 2020, closing a stake of 169,931 shares — an estimated $313K sold.

Fidelity International first reported a position in COGT in Q1 2018 and held it in 10 quarters. The position peaked at $16.3M in Q2 2018. 35 funds tracked by Wall St. Rank hold COGT as of Q3 2020.

Fidelity International reported no remaining Cogent Biosciences position as of Q3 2020 after selling out during the quarter.
Fidelity International sold 169,931 Cogent Biosciences shares in Q3 2020, an estimated $313K.
Fidelity International first reported a position in Cogent Biosciences in Q1 2018 and held it in 10 quarters.
Fidelity International's Cogent Biosciences position peaked at $16.3M in Q2 2018.
35 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2020.

Based on Fidelity International's 13F filing for Q3 2020, filed 13 Nov 2020.